Cargando...

Lessons From LEADER – All-round Leadership

The large multinational, randomised, double-blind LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcome Results - A Long Term Evaluation) trial recently reported the cardiovascular (CV) benefits achieved with liraglutide therapy in type 2 diabetes mellitus (T2DM). T...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Eur Endocrinol
Autor principal: Kalra, Sanjay
Formato: Artigo
Lenguaje:Inglês
Publicado: Touch Medical Media 2016
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5813445/
https://ncbi.nlm.nih.gov/pubmed/29632591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17925/EE.2016.12.02.76
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!